These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 3005209

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.
    Tsuruo T, Iida-Saito H, Kawabata H, Oh-hara T, Hamada H, Utakoji T.
    Jpn J Cancer Res; 1986 Jul; 77(7):682-92. PubMed ID: 3091555
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antitumor activity of DA-125, a novel anthracycline, in human gastric and pulmonary adenocarcinoma cells resistant to adriamycin and cisplatin.
    Hong WS, Jung HY, Yang SK, Kim HR, Min YI.
    Anticancer Res; 1997 Jul; 17(5A):3613-6. PubMed ID: 9413212
    [Abstract] [Full Text] [Related]

  • 7. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M, Komeshima N, Naito M, Isoe T, Otake N, Tsuruo T.
    Cancer Res; 1991 Jan 01; 51(1):157-61. PubMed ID: 1988080
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High-level, unstable adriamycin resistance in a Chinese hamster mutant cell line with double minute chromosomes.
    Howell N, Belli TA, Zaczkiewicz LT, Belli JA.
    Cancer Res; 1984 Sep 01; 44(9):4023-9. PubMed ID: 6744317
    [Abstract] [Full Text] [Related]

  • 10. Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance.
    Guo H, Lu G, Xiong X, Dong J, Liu S.
    Chin Med J (Engl); 1997 Mar 01; 110(3):167-72. PubMed ID: 9594332
    [Abstract] [Full Text] [Related]

  • 11. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184.
    Moy BC, Petzold GL, Badiner GJ, Kelly RC, Aristoff PA, Adams EG, Li LH, Bhuyan BK.
    Cancer Res; 1990 Apr 15; 50(8):2485-92. PubMed ID: 2317831
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Roles of p53 in adriamycin-induced cell death and in acquisition of adriamycin resistance in adult T-cell leukemia (ATL) cells].
    Cho Y.
    Hokkaido Igaku Zasshi; 1999 May 15; 74(3):239-48. PubMed ID: 10422567
    [Abstract] [Full Text] [Related]

  • 15. Comparison of adriamycin- and ouabain-induced cytotoxicity and inhibition of 86rubidium transport in wild-type and ouabain-resistant C3H/10T1/2 mouse fibroblasts.
    Landolph JR, Bhatt RS, Telfer N, Heidelberger C.
    Cancer Res; 1980 Dec 15; 40(12):4581-8. PubMed ID: 7438092
    [Abstract] [Full Text] [Related]

  • 16. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
    Tsuruo T.
    Prog Clin Biol Res; 1986 Dec 15; 223():203-16. PubMed ID: 3468516
    [Abstract] [Full Text] [Related]

  • 17. Expression of a herpes simplex virus glycoprotein in two clonal lines of hamster cells transformed by herpes simplex virus type 2.
    Kimura S, Okazaki K.
    Gan; 1984 Apr 15; 75(4):317-24. PubMed ID: 6329882
    [Abstract] [Full Text] [Related]

  • 18. Expression of herpes simplex virus common surface antigens and malignancy by clonal cells of a herpes simplex virus type 2-transformed line.
    Kimura S, Okazaki K, Tanaka S, Yoshida N.
    Gan; 1981 Dec 15; 72(6):834-41. PubMed ID: 6281115
    [Abstract] [Full Text] [Related]

  • 19. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
    Dong J, Naito M, Tatsuta T, Seimiya H, Johdo O, Tsuruo T.
    Oncol Res; 1995 Dec 15; 7(5):245-52. PubMed ID: 8534930
    [Abstract] [Full Text] [Related]

  • 20. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA, Cucchi CA, Lee JB, Flatow JL, Rosowsky A, Frei E.
    Cancer Res; 1986 Sep 15; 46(9):4379-83. PubMed ID: 3731096
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.